Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 7
1968 6
1969 6
1970 4
1971 6
1972 2
1973 4
1974 3
1975 8
1976 4
1977 5
1978 3
1979 9
1980 6
1981 4
1982 9
1983 5
1984 7
1985 4
1986 5
1987 7
1988 7
1989 17
1990 13
1991 10
1992 6
1993 12
1994 6
1995 8
1996 5
1997 8
1998 5
1999 14
2000 9
2001 11
2002 4
2003 9
2004 6
2005 3
2006 9
2007 7
2008 9
2009 7
2010 5
2011 6
2012 7
2013 5
2014 5
2015 5
2016 6
2017 2
2018 1
2019 1
2020 2
2021 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

329 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.
Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC, Sarwer DB, Coutifaris C, Dokras A. Legro RS, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):4048-58. doi: 10.1210/jc.2015-2778. Epub 2015 Sep 24. J Clin Endocrinol Metab. 2015. PMID: 26401593 Free PMC article. Clinical Trial.
INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl estradiol 20 mcg/1 mg norethindrone acetate) ("OCP"); 2) lifestyle modification consisting of caloric restriction with meal replace …
INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl es
Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial.
Balle C, Konstantinus IN, Jaumdally SZ, Havyarimana E, Lennard K, Esra R, Barnabas SL, Happel AU, Moodie Z, Gill K, Pidwell T, Karaoz U, Brodie E, Maseko V, Gamieldien H, Bosinger SE, Myer L, Bekker LG, Passmore JS, Jaspan HB. Balle C, et al. Nat Commun. 2020 Nov 4;11(1):5578. doi: 10.1038/s41467-020-19382-9. Nat Commun. 2020. PMID: 33149114 Free PMC article. Clinical Trial.
To investigate this, 130 HIV negative adolescent females aged 15-19 years were enrolled into a substudy of UChoose, an open-label randomized crossover study (NCT02404038), comparing acceptability and contraceptive product preference as a proxy for HIV prevention delivery methods. …
To investigate this, 130 HIV negative adolescent females aged 15-19 years were enrolled into a substudy of UChoose, an open-label randomized …
Combined oral contraceptives in women with systemic lupus erythematosus.
Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von Feldt J, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP; OC-SELENA Trial. Petri M, et al. N Engl J Med. 2005 Dec 15;353(24):2550-8. doi: 10.1056/NEJMoa051135. N Engl J Med. 2005. PMID: 16354891 Free article. Clinical Trial.
METHODS: A total of 183 women with inactive (76 percent) or stable active (24 percent) systemic lupus erythematosus at 15 U.S. sites were randomly assigned to receive either oral contraceptives (triphasic ethinyl estradiol at a dose of 35 microg plus norethindron
METHODS: A total of 183 women with inactive (76 percent) or stable active (24 percent) systemic lupus erythematosus at 15 U.S. sites were ra …
The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
Moutos D, Smith S, Zacur H. Moutos D, et al. Contraception. 1995 Aug;52(2):105-9. doi: 10.1016/s0010-7824(95)00137-9. Contraception. 1995. PMID: 8536446 Free article. Clinical Trial.
Dehydroepiandrosterone sulfate was suppressed to a similar degree with ethinyl estradiol 35 micrograms/norethindrone 1 mg and ethinyl estradiol 35 micrograms/norethindrone 0.5 mg, but ethinyl estradiol 50 micrograms/noret
Dehydroepiandrosterone sulfate was suppressed to a similar degree with ethinyl estradiol 35 micrograms/norethindrone 1 …
Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.
Kaunitz AM. Kaunitz AM. Contraception. 2000 May;61(5):295-302. doi: 10.1016/s0010-7824(00)00108-6. Contraception. 2000. PMID: 10906499 Clinical Trial.
The contraceptive efficacy, cycle control, and safety of a new low-dose, triphasic desogestrel/ethinyl estradiol oral contraceptive (CTR 77, Cyclessa(TM)) was compared to that of a marketed, triphasic norethindrone/ethinyl estradiol oral contrac …
The contraceptive efficacy, cycle control, and safety of a new low-dose, triphasic desogestrel/ethinyl estradiol oral contrace …
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Sulak P, Lippman J, Siu C, Massaro J, Godwin A. Sulak P, et al. Contraception. 1999 Mar;59(3):161-6. doi: 10.1016/s0010-7824(99)00026-8. Contraception. 1999. PMID: 10382078 Clinical Trial.
This six-cycle, multicenter, open-label, randomized study compared the clinical experience of two low-dose oral contraceptives (OC): a triphasic OC containing norgestimate (NGM) and 35 micrograms ethinyl estradiol (EE) (Ortho Tri-Cyclen) and a monophasic OC containi …
This six-cycle, multicenter, open-label, randomized study compared the clinical experience of two low-dose oral contraceptives (OC): a triph …
A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement.
Williams SR, Frenchek B, Speroff T, Speroff L. Williams SR, et al. Am J Obstet Gynecol. 1990 Feb;162(2):438-46. doi: 10.1016/0002-9378(90)90402-s. Am J Obstet Gynecol. 1990. PMID: 2309827 Clinical Trial.
In a blinded, prospective, dose-response pilot study of continuous estrogen-progestin replacement therapy, 77 thin, nonsmoking, white women, who were 12 to 60 months postmenopausal and had normal medical histories, were randomly assigned to receive one of five dose combinations o …
In a blinded, prospective, dose-response pilot study of continuous estrogen-progestin replacement therapy, 77 thin, nonsmoking, white women, …
Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol.
van Giersbergen PL, Halabi A, Dingemanse J. van Giersbergen PL, et al. Int J Clin Pharmacol Ther. 2006 Mar;44(3):113-8. doi: 10.5414/cpp44113. Int J Clin Pharmacol Ther. 2006. PMID: 16550733 Clinical Trial.
Treatment A consisted of a single dose of OrthoNovum containing 1 mg norethisterone (norethindrone) and 35 microg ethinyl estradiol. Treatment B consisted of bosentan, 125 mg b.i.d. for 7 days plus concomitant norethisterone and ethinyl
Treatment A consisted of a single dose of OrthoNovum containing 1 mg norethisterone (norethindrone) and 35 microg ethinyl
Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB, Donahue SR, Collins JM, Flockhart DA, Thacker D, Abernethy DR. Trapnell CB, et al. Clin Pharmacol Ther. 1998 Dec;64(6):597-602. doi: 10.1016/S0009-9236(98)90050-9. Clin Pharmacol Ther. 1998. PMID: 9871424 Clinical Trial.
OBJECTIVE: To evaluate the effect of thalidomide on the plasma pharmacokinetics of ethinyl estradiol (INN, ethinylestradiol) and norethindrone (INN, norethisterone). ...An open-label crossover study was conducted to evaluate the effect of thalidomide o …
OBJECTIVE: To evaluate the effect of thalidomide on the plasma pharmacokinetics of ethinyl estradiol (INN, ethinylestradiol) a …
The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. Hendrix CW, et al. Clin Pharmacol Ther. 2004 May;75(5):464-75. doi: 10.1016/j.clpt.2004.01.003. Clin Pharmacol Ther. 2004. PMID: 15116059 Clinical Trial.
RESULTS: The addition of isotretinoin to the oral contraceptive regimen resulted in small and inconsistent, although statistically significant (P <.04), decreases in the concentrations of both ethinyl estradiol (9% decrease in area under the plasma concentration- …
RESULTS: The addition of isotretinoin to the oral contraceptive regimen resulted in small and inconsistent, although statistically significa …
329 results